Tag Archive
OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries (News-Medical-Net)
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex’ license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with... »
Rexahn, TheraTarget form nano science research collaboration (PharmaBiz)
Rexahn Pharmaceuticals, Inc, a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, and TheraTarget, Inc, a developer of innovative polymer therapeutics for the treatment of cancer, announced the formation of a joint research collaboration agreement. (read here…) Related items Rexahn to close licensing and stock purchase agreements with Teva Pharmaceutical (News-Medical-Net) Biomoda applauds... »
Mutated IDH1 gene linked to the progression of gliomas (News-Medical-Net)
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. (read here…) Related items OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries (News-Medical-Net) Medivir AB announces license agreement with Daewoong Pharmaceutical... »
Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and Development (ITNews)
DUBAI, UAE, October 6 /PRNewswire/ — Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, has ventured into biotechnology and nanotechnology-based research and manufacturing capabilities. (more here…) Related items Business : Neopharma to Bring Nanotechnology to Region (Khaleej Times) Neopharma announces expansion into biotechnology and nanotechnology-based research and development (Zawya) Abu Dhabi’s Neopharma to bring nanotechnology to region (MENAFN) Paragon Airheater Technologies Announces... »
Business : Neopharma to Bring Nanotechnology to Region (Khaleej Times)
ABU DHABI — Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, on Sunday announced Dh250 million expansion programme to enter into biotechnology and nanotechnology-based research and manufacturing capabilities. (more here…) Related items Neopharma announces expansion into biotechnology and nanotechnology-based research and development (Zawya) Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and Development (ITNews) Abu Dhabi’s Neopharma to bring nanotechnology to region... »
